Genetics of Crohn disease, an archetypal inflammatory barrier disease (original) (raw)
Becker, K. G. et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl Acad. Sci. USA95, 9979–9984 (1998). ArticleCASPubMedPubMed Central Google Scholar
Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med.347, 911–920 (2002). Seminal paper that highlights the co-morbidities of different inflammatory barrier diseases and provides an epidemiological link to infection. ArticlePubMed Google Scholar
Crohn, B. B., Ginzburg, L. & Oppenheimer, G. D. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. JAMA251, 73–79 (1984). ArticleCASPubMed Google Scholar
Binder, V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract. Res. Clin. Gastroenterol.18, 463–479 (2004). ArticlePubMed Google Scholar
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet351, 1225–1232 (1998).
Gent, A. E., Hellier, M. D., Grace, R. H., Swarbrick, E. T. & Coggon, D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet343, 766–767 (1994). ArticleCASPubMed Google Scholar
Hampe, J., Heymann, K., Krawczak, M. & Schreiber, S. Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure. Int. J. Colorectal Dis.18, 413–417 (2003). ArticlePubMed Google Scholar
Kuster, W., Pascoe, L., Purrmann, J., Funk, S. & Majewski, F. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am. J. Med. Genet.32, 105–108 (1989). ArticleCASPubMed Google Scholar
Tysk, C., Lindberg, E., Jarnerot, G. & Floderus Myrhed, B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut29, 990–996 (1988). ArticleCASPubMedPubMed Central Google Scholar
Satsangi, J., Rosenberg, W. M. C. & Jewell, D. P. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol.6, 413–416 (1994). Google Scholar
Orholm, M. et al. Familial occurrence of inflammatory bowel disease. N. Engl. J. Med.324, 84–88 (1991). ArticleCASPubMed Google Scholar
Meucci, G. et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology103, 514–519 (1992). ArticleCASPubMed Google Scholar
Thompson, N. P., Driscoll, R., Pounder, R. E. & Wakefield, A. J. Genetics versus environment in inflammatory bowel disease: results of a British twin study. Br. Med. J.312, 95–96 (1996). ArticleCAS Google Scholar
Orholm, M. et al. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. Br. Med. J.306, 20–24 (1993). ArticleCAS Google Scholar
Koutroubakis, I., Manousos, O. N., Meuwissen, S. G. & Pena, A. S. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology43, 381–393 (1996). CASPubMed Google Scholar
Parkes, M., Satsangi, J. & Jewell, D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin. Exp. Immunol.113, 28–32 (1998). ArticleCASPubMedPubMed Central Google Scholar
Mahler, M. et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol.274, G544–G551 (1998). CASPubMed Google Scholar
Bristol, I. J. et al. Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm. Bowel Dis.6, 290–302 (2000). ArticleCASPubMed Google Scholar
Mahler, M. et al. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics55, 147–156 (1999). ArticleCASPubMed Google Scholar
Farmer, M. A. et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc. Natl Acad. Sci. USA98, 13820–13825 (2001). ArticleCASPubMedPubMed Central Google Scholar
Kerem, B. et al. Identification of the cystic fibrosis gene: genetic analysis. Science245, 1073–1080 (1989). ArticleCASPubMed Google Scholar
Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet.33, S228–S237 (2003). ArticleCAS Google Scholar
Glazier, A. M., Nadeau, J. H. & Aitman, T. J. Finding genes that underlie complex traits. Science298, 2345–2349 (2002). ArticleCASPubMed Google Scholar
Salanti, G., Sanderson, S. & Higgins, J. P. Obstacles and opportunities in meta-analysis of genetic association studies. Genet. Med.7, 13–20 (2005). ArticlePubMed Google Scholar
Pritchard, J. K. & Cox, N. J. The allelic architecture of human disease genes: common disease-common variant...or not? Hum. Mol. Genet.11, 2417–2423 (2002). ArticleCASPubMed Google Scholar
Valentonyte, R. et al. Sarcoidosis is associated with a truncating splice site mutation in the BTNL2 gene. Nature Genet.37, 357–364 (2005). ArticleCASPubMed Google Scholar
Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature423, 506–511 (2003). ArticleCASPubMed Google Scholar
Silverberg, M. S. et al. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut49, 773–776 (2001). ArticleCASPubMedPubMed Central Google Scholar
Schaid, D. J. Genetic epidemiology and haplotypes. Genet. Epidemiol.27, 317–320 (2004). ArticlePubMed Google Scholar
Schaid, D. J. & Jacobsen, S. J. Biased tests of association: comparisons of allele frequencies when departing from Hardy–Weinberg proportions. Am. J. Epidemiol.149, 706–711 (1999). ArticleCASPubMed Google Scholar
Spielman, R. S., McGinnis, R. E. & Ewens, W. J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet.52, 506–516 (1993). The authors provide an introduction to transmission analysis for association studies. CASPubMedPubMed Central Google Scholar
Morton, N. E. & Collins, A. Tests and estimates of allelic association in complex inheritance. Proc. Natl Acad. Sci. USA95, 11389–11393 (1998). ArticleCASPubMedPubMed Central Google Scholar
Zollner, S. et al. Evidence for extensive transmission distortion in the human genome. Am. J. Hum. Genet.74, 62–72 (2004). ArticlePubMed Google Scholar
Geesaman, B. J. et al. Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan. Proc. Natl Acad. Sci. USA100, 14115–14120 (2003). ArticleCASPubMedPubMed Central Google Scholar
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics55, 997–1004 (1999). ArticleCASPubMed Google Scholar
Pritchard, J. K. & Rosenberg, N. A. Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet.65, 220–228 (1999). ArticleCASPubMedPubMed Central Google Scholar
Hugot, J. P. et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature379, 821–823 (1996). ArticleCASPubMed Google Scholar
Satsangi, J. et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genet.14, 199–202 (1996). ArticleCASPubMed Google Scholar
Cho, J. H. et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1. Proc. Natl Acad. Sci. USA95, 7502–7507 (1998). ArticleCASPubMedPubMed Central Google Scholar
Hampe, J. et al. A genome-wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet.64, 808–816 (1999). ArticleCASPubMedPubMed Central Google Scholar
Rioux, J. D. et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet.66, 1863–1870 (2000). ArticleCASPubMedPubMed Central Google Scholar
Curran, M. E. et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology115, 1066–1071 (1998). ArticleCASPubMed Google Scholar
Brant, S. R. et al. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology115, 1056–1061 (1998). ArticleCASPubMed Google Scholar
Cavanaugh, J. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am. J. Hum. Genet.68, 1165–1171 (2001). ArticleCASPubMed Google Scholar
Hampe, J. et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl Acad. Sci. USA99, 321–326 (2002). ArticleCASPubMed Google Scholar
van Heel, D. A. et al. The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. Hum. Mol. Genet.12, 2569–2575 (2003). ArticleCASPubMed Google Scholar
van Heel, D. A. et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum. Mol. Genet.11, 1281–1289 (2002). ArticleCASPubMed Google Scholar
Nomura, E. et al. Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative colitis. Genes Immun.5, 477–483 (2004). ArticleCASPubMed Google Scholar
van Heel, D. A. et al. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet.13, 763–770 (2004). ArticleCASPubMed Google Scholar
Ogura, Y. et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem.276, 4812–4818 (2001). This is the first description of NOD2. ArticleCASPubMed Google Scholar
Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature411, 599–603 (2001). ArticleCASPubMed Google Scholar
Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature411, 603–606 (2001). ArticleCASPubMed Google Scholar
Hampe, J. et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet357, 1925–1928 (2001). References 52–54 are seminal papers that describe NOD2 (CARD15) as the first disease gene in Crohn disease. ArticleCASPubMed Google Scholar
Stoll, M. et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nature Genet.36, 476–480 (2004). ArticleCASPubMed Google Scholar
Yamazaki, K. et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J. Hum. Genet.49, 664–668 (2004). ArticleCASPubMed Google Scholar
Cuthbert, A. P. et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology122, 867–874 (2002). ArticleCASPubMed Google Scholar
Wakabayashi, M. et al. Interaction of lp-dlg/KIAA0583, a membrane-associated guanylate kinase family protein, with vinexin and β-catenin at sites of cell–cell contact. J. Biol. Chem.278, 21709–21714 (2003). ArticleCASPubMed Google Scholar
Rioux, J. D. et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genet.29, 223–228 (2001). ArticleCASPubMed Google Scholar
Giallourakis, C. et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am. J. Hum. Genet.73, 205–211 (2003). ArticleCASPubMedPubMed Central Google Scholar
Peltekova, V. D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genet.36, 471–475 (2004). ArticleCASPubMed Google Scholar
Inoue, N. et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology123, 86–91 (2002). ArticleCASPubMed Google Scholar
Croucher, P. J. P. et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet.11, 6–16 (2003). ArticleCASPubMed Google Scholar
Guo, Q. S., Xia, B., Jiang, Y., Qu, Y. & Li, J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J. Gastroenterol.10, 1069–1071 (2004). ArticleCASPubMedPubMed Central Google Scholar
Risch, N. J. Searching for genetic determinants in the new millennium. Nature405, 847–856 (2000). ArticleCASPubMed Google Scholar
Ma, Y. et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm. Bowel Dis.5, 271–278 (1999). ArticleCASPubMed Google Scholar
Mirza, M. M. et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am. J. Hum. Genet.72, 1018–1022 (2003). ArticleCASPubMedPubMed Central Google Scholar
McGovern, D. P., Van Heel, D. A., Negoro, K., Ahmad, T. & Jewell, D. P. Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am. J. Hum. Genet.73, 1465–1466 (2003). ArticleCASPubMedPubMed Central Google Scholar
van Heel, D. A. et al. Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics. Am. J. Med. Genet.111, 253–259 (2002). ArticlePubMed Google Scholar
The International HapMap Consortium. The International HapMap Project. Nature426, 789–796 (2003).
Albrecht, M., Domingues, F. S., Schreiber, S. & Lengauer, T. Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett.554, 520–528 (2003). ArticleCASPubMed Google Scholar
Bird, T. D., Jarvik, G. P. & Wood, N. W. Genetic association studies: genes in search of diseases. Neurology57, 1153–1154 (2001). ArticleCASPubMed Google Scholar
Daly, M. J. & Rioux, J. D. New approaches to gene hunting in IBD. Inflamm. Bowel Dis.10, 312–317 (2004). ArticlePubMed Google Scholar
Harton, J. A., Linhoff, M. W., Zhang, J. & Ting, J. P. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J. Immunol.169, 4088–4093 (2002). ArticleCASPubMed Google Scholar
Ting, J. P. & Davis, B. K. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol.23, 387–414 (2005). ArticleCASPubMed Google Scholar
Wyatt, J., Vogelsang, H., Hubl, W., Waldhoer, T. & Lochs, H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet341, 1437–1439 (1993). ArticleCASPubMed Google Scholar
Irvine, E. J. & Marshall, J. K. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology119, 1740–1744 (2000). ArticleCASPubMed Google Scholar
Katz, K. D. et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology97, 927–931 (1989). ArticleCASPubMed Google Scholar
Soderholm, J. D. et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut44, 96–100 (1999). ArticleCASPubMedPubMed Central Google Scholar
Thjodleifsson, B. et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology124, 1728–1737 (2003). ArticlePubMed Google Scholar
Gewirtz, A. T. Intestinal epithelial Toll-like receptors: to protect. And serve? Curr. Pharm. Des.9, 1–5 (2003). ArticleCASPubMed Google Scholar
Jobin, C. Intestinal epithelial cells and innate immunity in the intestine: is CARD15/Nod2 another player? Gastroenterology124, 1145–1149 (2003). ArticleCASPubMed Google Scholar
Cario, E. et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol.164, 966–972 (2000). ArticleCASPubMed Google Scholar
Abreu, M. T. et al. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol.167, 1609–1616 (2001). ArticleCASPubMed Google Scholar
Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S. & Richter-Dahlfors, A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med.195, 559–570 (2002). ArticleCASPubMedPubMed Central Google Scholar
Hisamatsu, T. et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology124, 993–1000 (2003). ArticleCASPubMed Google Scholar
Rosenstiel, P. et al. TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology124, 1001–1009 (2003). ArticleCASPubMed Google Scholar
O'Neil, D. A. et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol.163, 6718–6724 (1999). CASPubMed Google Scholar
Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem.278, 8869–8872 (2003). ArticleCASPubMed Google Scholar
Inohara, N. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: Implications for Crohn's disease. J. Biol. Chem.278, 5509–5512 (2003). References 89 and 90 identify muramyl dipeptide as the main ligand for NOD2. ArticleCASPubMed Google Scholar
Kobayashi, K. S. et al. _Nod2_-dependent regulation of innate and adaptive immunity in the intestinal tract. Science307, 731–734 (2005). The firstNod2/Card15murine knockout model that supports the 'chronic infection hypothesis' for Crohn disease through NOD2 sensing deficiency. Detection of a reduced cyrptdin expression on intestinal epithelial cells as the main consequence of a lack of NOD2 function. ArticleCASPubMed Google Scholar
Wehkamp, J. et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut53, 1658–1664 (2004). ArticleCASPubMedPubMed Central Google Scholar
Netea, M. G. et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur. J. Immunol.34, 2052–2059 (2004). ArticleCASPubMed Google Scholar
Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science307, 734–738 (2005). The authors describe a transgenic murine model ofNOD2/CARD151007fsInsC leading to an alternative hypothesis for NF-κB activation in the intestinal mucosa in Crohn disease. ArticleCASPubMed Google Scholar
Akey, J. M., Zhang, G., Zhang, K., Jin, L. & Shriver, M. D. Interrogating a high-density SNP map for signatures of natural selection. Genome Res.12, 1805–1814 (2002). ArticleCASPubMedPubMed Central Google Scholar
Shin, C. & Manley, J. L. Cell signalling and the control of pre-mRNA splicing. Nature Rev. Mol. Cell Biol.5, 727–738 (2004). ArticleCAS Google Scholar
Dinesh-Kumar, S. P. & Baker, B. J. Alternatively spliced N resistance gene transcripts: their possible role in tobacco mosaic virus resistance. Proc. Natl Acad. Sci. USA97, 1908–1013 (2000). ArticleCASPubMedPubMed Central Google Scholar
Dinesh-Kumar, S. P., Tham, W. H. & Baker, B. J. Structure–function analysis of the tobacco mosaic virus resistance gene. N. Proc. Natl Acad. Sci. USA97, 14789–14794 (2000). ArticleCASPubMed Google Scholar
Resch, A. et al. Assessing the impact of alternative splicing on domain interactions in the human proteome. J. Proteome Res.3, 76–83 (2004). ArticleCASPubMed Google Scholar
Hiller, M. et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity. Nature Genet.36, 1255–1257 (2004). ArticleCASPubMed Google Scholar
Hooper, L. V. & Gordon, J. I. Commensal host-bacterial relationships in the gut. Science292, 1115–1118 (2001). ArticleCASPubMed Google Scholar
Macpherson, A. J. & Harris, N. L. Interactions between commensal intestinal bacteria and the immune system. Nature Rev. Immunol.4, 478–485 (2004). ArticleCAS Google Scholar
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell118, 229–241 (2004). This is a seminal paper that describes the symbiotic interaction between intestinal epithelial cells and the mucosal flora. ArticleCASPubMed Google Scholar
Alley, C. D., Kiyono, H. & McGhee, J. R. Murine bone marrow IgA responses to orally administered sheep erythrocytes. J. Immunol.136, 4414–4419 (1986). CASPubMed Google Scholar
Fanaro, S., Chierici, R., Guerrini, P. & Vigi, V. Intestinal microflora in early infancy: composition and development. Acta Paediatr.91, S48–S55 (2003). Google Scholar
Dai, D. & Walker, W. A. Protective nutrients and bacterial colonization in the immature human gut. Adv. Pediatr.46, 353–382 (1999). CASPubMed Google Scholar
Walker, W. A. Role of nutrients and bacterial colonization in the development of intestinal host defense. J. Pediatr. Gastroenterol. Nutr.30, S2–S7 (2000). ArticlePubMed Google Scholar
Smith, S., Vaughan, E. E. & De Vos, W. M. Quorum sensing within the gut. Microbial Ecol. Health Dis.2, S81–S92 (2000). Google Scholar
Falcao, J. P., Sharp, F. & Sperandio, V. Cell-to-cell signaling in intestinal pathogens. Curr. Issues Intest. Microbiol.5, 9–17 (2004). CASPubMed Google Scholar
Schultz, M. et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol.276, G1461–G1472 (1999). CASPubMed Google Scholar
Ott, S. J. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut53, 685–693 (2004). ArticleCASPubMedPubMed Central Google Scholar
Duchmann, R. et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol.102, 448–455 (1995). ArticleCASPubMedPubMed Central Google Scholar
Yachi, S. & Loreau, M. Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. Proc. Natl Acad. Sci. USA96, 1463–1468 (1999). ArticleCASPubMedPubMed Central Google Scholar
Naser, S. A., Ghobrial, G., Romero, C. & Valentine, J. F. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet364, 1039–1044 (2004). ArticlePubMed Google Scholar
Sartor, R. B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology126, 1620–1633 (2004). ArticlePubMed Google Scholar
Kruis, W. Review article: antibiotics and probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther.20 (Suppl. 4), 75–78 (2004). ArticleCASPubMed Google Scholar
Kalliomaki, M. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet357, 1076–1079 (2001). ArticleCASPubMed Google Scholar
Newman, L. S., Rose, C. S. & Maier, L. A. Sarcoidosis. N. Engl. J. Med.336, 1224–1234 (1997). ArticleCASPubMed Google Scholar
Schurmann, M. et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med.164, 840–846 (2001). ArticleCASPubMed Google Scholar
Foley, P. J. et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell Mol. Biol.25, 272–277 (2001). ArticleCASPubMed Google Scholar
Rossman, M. D. et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet.73, 720–735 (2003). ArticleCASPubMedPubMed Central Google Scholar
Stenzel, A. et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum. Genet.114, 377–385 (2004). ArticleCASPubMed Google Scholar
Leipe, D. D., Koonin, E. V. & Aravind, L. STAND, a class of P-loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. J. Mol. Biol.343, 1–28 (2004). ArticleCASPubMed Google Scholar
Agostini, L. et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity20, 319–325 (2004). ArticleCASPubMed Google Scholar
O'Connor, W. Jr, Harton, J. A., Zhu, X., Linhoff, M. W. & Ting, J. P. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-κB suppressive properties. J. Immunol.171, 6329–6333 (2003). ArticleCASPubMed Google Scholar
Albrecht, M., Lengauer, T. & Schreiber, S. Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence. Bioinformatics19, 2171–2175 (2003). ArticleCASPubMed Google Scholar